Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ZeroAqua Technologies is a U.S. medical device and decontamination technology company focused on UVC LED-based systems for infection prevention. The company became known during the COVID-19 period for its PearlSurface UVC device used to decontaminate N95 respirators and related personal protective equipment for healthcare settings. Publicly available materials describe ZeroAqua as a subsidiary of Zenger LLC serving medical device and residential markets, with additional positioning in sports, entertainment, and luxury sectors. The company appears to be a commercial-stage device business rather than a therapeutics developer, and there is no evidence of a drug pipeline or clinical-stage biopharma programs. Its healthcare relevance is tied to hospital and medical decontamination workflows rather than diagnostics or therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ZeroAqua Technologies.